Skip to main content

Table 1 Characteristics of the study sample in 2005 (n = 35,102)

From: The impact of Medicare prescription drug coverage on the use of antidementia drugs

 

Pharmacy benefit group

 

No coverage (n = 3,939)

$150 cap (n = 2,662)

$350 cap (n = 19,014)

No cap (n = 9,487)

Female sex, No. (%)

2,183 (55.42)*

1,658 (62.28)*

11,806 (62.09)*

4,984 (52.54)

Age, y, No. (%)

    

  65-74

1,866 (47.37)*

1,323 (49.70)*

9,983 (52.50)*

5,755 (60.66)

  75-84

1,746 (44.33)*

1,080 (40.57)*

7,478 (39.33)*

3,232 (34.07)

  ≥85

327 (8.30)*

259 (9.73)*

1,553 (8.17)*

500 (5.27)

Race, mean (SE)

    

  White

0.930 (0.002)*

0.960 (0.001)*

0.919 (0.001)*

0.921 (0.001)

  African American

0.052 (0.002)*

0.024 (0.001)*

0.060 (0.001)*

0.057 (0.001)

Status below poverty line, mean (SE)

    

  <100%

0.106 (0.001)*

0.111 (0.001)*

0.101 (0.000)*

0.099 (0.001)

  100-200%

0.183 (0.001)*

0.209 (0.001)*

0.172 (0.000)*

0.169 (0.001)

  >200%

0.712 (0.002)*

0.680 (0.002)*

0.727 (0.001)*

0.732 (0.001)

Urban residence, mean (SE)

0.737 (0.005)*

0.577 (0.007)*

0.791 (0.002)

0.797 (0.003)

Income, US dollars, median (SE)

37,573.77 (159.01)*

34,839.85 (111.25)*

38,957.08 (78.64)*

39,501.05 (110.80)

Comorbidity, No. (%)

    

  Congestive heart failure

507 (12.87)

381 (14.31)

2,656 (13.97)*

1,240 (13.07)

  Depression

259 (6.58)*

215 (8.08)

1,465 (7.71)

725 (7.64)

  Diabetes

905 (22.98)*

679 (25.51)

4,755 (25.01)

2,464 (25.97)

  Hypertension

2,554 (64.84)*

1,892 (71.07)

1,3640 (71.74)*

6,649 (70.09)

  Ischemic heart disease

1,110 (28.18)

757 (28.44)

5,551 (29.20)

2,796 (29.47)

Prospective risk score, mean (SE)

    

  2004

0.825 (0.011)

0.855 (0.014)

0.859 (0.005)

0.844 (0.008)

  2005

0.919 (0.012)

0.950 (0.016)

0.942 (0.006)

0.924 (0.009)

  2006

1.034 (0.015)

1.040 (0.017)

1.044 (0.007)

1.029 (0.010)

  2007

1.153 (0.017)

1.186 (0.020)*

1.176 (0.008)*

1.141 (0.011)

Use of medical services in 2005, mean (SE)

    

  Outpatient visits, No.

23.146 (0.407)*

25.158 (0.585)

25.134 (0.193)*

25.876 (0.287)

  Outpatient costs, US dollars

3,498.249 (92.900)*

3,532.557 (124.010)*

3,741.035 (47.238)

3,869.198 (65.966)

  Medical costs, US dollars

6,000.270 (186.796)

5,837.965 (226.731)

6,208.844 (87.559)

6,266.855 (130.414)

Prescriptions of antidementia drugs, mean (SE)

    

 2004-2007

    

  Aricept®

0.675 (0.064)*

0.841 (0.090)

0.878 (0.036)

0.908 (0.054)

  Razadyne®

0

0

0.008 (0.002)

0.019 (0.005)

  Exelon®

0.079 (0.023)*

0.085 (0.032)*

0.100 (0.012)*

0.228 (0.031)

  Cognex®

0

0

0

0

  Namenda®

0.476 (0.055)

0.343 (0.054)*

0.401 (0.023)*

0.498 (0.038)

 Pre–Part D

    

  Aricept®

0.172 (0.026)*

0.262 (0.039)

0.297 (0.016)

0.335 (0.025)

  Razadyne®

0

0

0.008 (0.002)

0.019 (0.005)

  Exelon®

0.032 (0.013)*

0.044 (0.018)*

0.040 (0.006)*

0.106 (0.016)

  Cognex®

0

0

0

0

  Namenda®

0.102 (0.018)

0.084 (0.019)*

0.096 (0.008)*

0.140 (0.015)

 Post–Part D

    

  Aricept®

0.503 (0.046)

0.579 (0.059)

0.581 (0.023)

0.573 (0.033)

  Razadyne®

0

0

0

0

  Exelon®

0.047 (0.013)*

0.041 (0.016)*

0.060 (0.007)*

0.122 (0.017)

  Cognex®

0

0

0

0

  Namenda®

0.375 (0.041)

0.259 (0.040)*

0.305 (0.017)

0.357 (0.026)

  1. Abbreviations: SE, standard error.
  2. *differences are statistically significant at p < 0.05 level compared to the No cap group.